FindTrial
Sign In

The role of individualised Homoeopathic medicine in the treatment of Psoriasis in age group 20-50 years

To ascertain the role of individualised Homoeopathic medicine in the treatment of -Psoriasis in age group 20 to 50 years - A randomized controlled trial - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/11/098088
Enrollment
100
Registered
2025-11-26
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L400- Psoriasis vulgaris Health Condition 2: L409- Psoriasis, unspecified

Interventions

Intervention1: to give homoeopathic medicine to the patients suffering from psoriasis: to give individualised Homoeopathic medicine on basis of similimum POTENCY - 30CH, 200CH Mode of administration-

Sponsors

Tantia university
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient aged 20- 50 years with clinically diagnosed psoriasis.2.Gender- both male and female. 3.Patients willing to comply with study protocols and provide informed consent

Exclusion criteria

Exclusion criteria: 1.Patients on concurrent conventional psoriasis treatment. 2. Pregnant or lactating individuals 3.Severe systemic disease or mental health conditions impacting compliances

Design outcomes

Primary

MeasureTime frame
Psoriasis area and severity index(PASI assessment scale)Timepoint: Four follow- ups at the interval of 15 days upto 3 months—

Secondary

MeasureTime frame
TO KNOW ETIOLOGICAL FACTORS IN CASES OF PSORIASISTimepoint: Four follow- ups at the interval of 15 days upto 3 months—

Countries

India

Contacts

Public ContactPriyanka Bhardwaj

Sri Ganganagar Homoeopathic Medical College Hospital and Research Institute

drjaspinderkapoor@gmail.com9887951889

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026